🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
148,46 USD
Máx. histórico
156,92
14 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-5,39%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,24%
Cierre anterior
150,33
Rango de hoy
146,28 – 149,59
Volumen hoy
10.884.998
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 118,77 (puede no estar actualizado)
- Dividend yield
- 2,26% (puede no estar actualizado)
- Precio objetivo analistas
- 150,42 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 03/06/1985 | 0,0212 USD |
| 28/02/1985 | 0,0212 USD |
| 03/12/1984 | 0,0212 USD |
| 31/08/1984 | 0,0199 USD |
| 29/05/1984 | 0,0199 USD |
| 01/03/1984 | 0,0199 USD |
| 29/11/1983 | 0,0199 USD |
| 29/08/1983 | 0,0186 USD |
| 31/05/1983 | 0,0186 USD |
| 28/02/1983 | 0,0186 USD |
| 30/11/1982 | 0,0186 USD |
| 30/08/1982 | 0,0186 USD |
| 01/06/1982 | 0,0186 USD |
| 01/03/1982 | 0,0186 USD |
| 01/12/1981 | 0,0186 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 07/11/1994 | 16,76 | 16,82 | 16,58 | 16,82 | +0,36% | 1,42% | 2.910.925 |
| 04/11/1994 | 17,00 | 17,06 | 16,70 | 16,76 | -0,35% | 2,11% | 3.254.669 |
| 03/11/1994 | 16,82 | 16,88 | 16,70 | 16,82 | +0,36% | 1,06% | 2.360.725 |
| 02/11/1994 | 17,06 | 17,12 | 16,76 | 16,76 | -1,75% | 2,10% | 3.589.819 |
| 01/11/1994 | 16,94 | 17,18 | 16,88 | 17,06 | +0,35% | 1,76% | 3.653.118 |
| 31/10/1994 | 17,18 | 17,41 | 17,00 | 17,00 | -1,04% | 2,43% | 6.536.166 |
| 28/10/1994 | 16,94 | 17,18 | 16,82 | 17,18 | +1,41% | 2,11% | 5.066.032 |
| 27/10/1994 | 16,52 | 16,94 | 16,46 | 16,94 | +2,90% | 2,89% | 4.919.731 |
| 26/10/1994 | 16,46 | 16,52 | 16,22 | 16,46 | +0,00% | 1,81% | 4.323.838 |
| 25/10/1994 | 16,46 | 16,64 | 16,40 | 16,46 | -1,08% | 1,45% | 3.259.490 |
| 24/10/1994 | 16,94 | 17,00 | 16,52 | 16,64 | -1,76% | 2,82% | 3.436.811 |
| 21/10/1994 | 17,12 | 17,12 | 16,94 | 16,94 | -1,39% | 1,05% | 5.496.970 |
| 20/10/1994 | 17,00 | 17,18 | 16,94 | 17,18 | +1,41% | 1,40% | 4.735.493 |
| 19/10/1994 | 16,88 | 17,00 | 16,76 | 16,94 | +0,00% | 1,41% | 4.959.974 |
| 18/10/1994 | 17,29 | 17,35 | 16,94 | 16,94 | -1,73% | 2,41% | 6.871.107 |
| 17/10/1994 | 17,18 | 17,35 | 17,18 | 17,24 | -0,34% | 1,04% | 3.022.432 |
| 14/10/1994 | 17,47 | 17,53 | 17,18 | 17,29 | -1,02% | 2,05% | 5.271.859 |
| 13/10/1994 | 17,65 | 17,77 | 17,41 | 17,47 | -1,01% | 2,03% | 5.682.256 |
| 12/10/1994 | 17,29 | 17,65 | 17,24 | 17,65 | +1,37% | 2,41% | 5.683.514 |
| 11/10/1994 | 17,18 | 17,59 | 17,18 | 17,41 | +1,39% | 2,43% | 6.590.243 |
| 10/10/1994 | 17,24 | 17,24 | 17,06 | 17,18 | -0,35% | 1,04% | 2.437.858 |
| 07/10/1994 | 17,00 | 17,24 | 17,00 | 17,24 | +1,05% | 1,40% | 3.566.973 |
| 06/10/1994 | 17,00 | 17,12 | 16,94 | 17,06 | -0,69% | 1,05% | 4.526.731 |
| 05/10/1994 | 17,18 | 17,24 | 17,00 | 17,18 | -1,03% | 1,39% | 7.269.976 |
| 04/10/1994 | 17,41 | 17,65 | 17,29 | 17,35 | -0,34% | 2,06% | 10.207.939 |
| 03/10/1994 | 17,06 | 17,41 | 17,06 | 17,41 | +2,46% | 2,10% | 7.664.234 |
| 30/09/1994 | 16,88 | 17,18 | 16,82 | 17,00 | +1,06% | 2,12% | 5.308.120 |
| 29/09/1994 | 17,00 | 17,06 | 16,70 | 16,82 | -1,05% | 2,11% | 4.347.523 |
| 28/09/1994 | 16,94 | 17,24 | 16,94 | 17,00 | -1,04% | 1,76% | 10.898.990 |
| 27/09/1994 | 16,64 | 17,18 | 16,58 | 17,18 | +3,23% | 3,58% | 10.336.424 |